An exploratory study of efficacy and safety of sodium phenylbutyrate in progressive familial intrahepatic cholestasis type 1
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2018
Price : $35 *
At a glance
- Drugs Sodium phenylbutyrate (Primary)
- Indications Intrahepatic cholestasis
- Focus Therapeutic Use
- 10 Nov 2018 Planned number of patients changed from 4 to 6.
- 10 Nov 2017 Status changed from not yet recruiting to recruiting.
- 03 Jul 2017 New trial record